Report
FREE
• Organto reported Q4 and 2026 financials, beating our expectations on revenue and gross margins, but missing slightly on EBITDA.
• Revenue came in at $60.8M for 2025 and $14.9M for Q4, compared to our estimates of $60.1M and $14.2M, respectively. Gross margins were 10.8% in Q4 vs. our 9.0%, reflecting meaningful improvements.
• EBITDA was $XXM for 2025 compared to our estimate of ($0.8M) and EBITDA for the quarter was ($0.3M) compared to our estimate of $0.2M
• Management will be hosting a conference call on May 4th at 12 PM EST. Click here to register.
Yesterday, after market close, Organto Foods (OGO:TSXV, OGOFF:OTCQX) reported Q4 and 2025 financial results, demonstrating a staggering 194% YoY revenue growth in 2025. Gross profit increased 197% YoY, with further improvements in Q4 with gross margins of 10.8%. We remain impressed by OGO’s financial results and expect continued rapid growth in 2026 with opportunity for M&A to push towards profitability. We are maintaining our BUY rating and $1.25/share target price on Organto Foods.
Q4 and 2025 Highlights
• OGO reported $60.8M in revenue in 2025 compared to our estimate of $60.1M. This represented 194% YoY growth, building on the 48% growth posted in 2024. Q4 Revenue was $14.9M (+132% YoY) vs. our estimate of $14.2M. Management attributed XYZ.
• Gross margin came in at 8.6% and 10.8% for the year and the quarter, respectively, nicely beating our estimates of 8.1% and 9.0%. Q4 represented OGO’s highest gross margins since Q3/24.
• 2025 EBITDA came in at $XXM vs. our estimate of ($0.8M) while Q4 EBITDA was ($0.3M) vs. our estimate of $0.2M. We remind readers that this is not adjusted for SBC. While OGO did not achieve its goal of being EBITDA positive in 2025, we believe it is on the right track and now is reaching the scale required.
• SG&A rose XYZ.
• OCF came in at $XXM for 2025 and $XXM for Q4.
• OGO ended the year with $6.2M in cash (incl. restricted cash) and $0.2M in debt. The balance sheet is in a strong place relative to OGO’s past, with a current ratio of XYZ.
OGO: Finishing 2025 with 194% YoY Revenue Growth
What you need to know:• Organto reported Q4 and 2026 financials, beating our expectations on revenue and gross margins, but missing slightly on EBITDA.
• Revenue came in at $60.8M for 2025 and $14.9M for Q4, compared to our estimates of $60.1M and $14.2M, respectively. Gross margins were 10.8% in Q4 vs. our 9.0%, reflecting meaningful improvements.
• EBITDA was $XXM for 2025 compared to our estimate of ($0.8M) and EBITDA for the quarter was ($0.3M) compared to our estimate of $0.2M
• Management will be hosting a conference call on May 4th at 12 PM EST. Click here to register.
Yesterday, after market close, Organto Foods (OGO:TSXV, OGOFF:OTCQX) reported Q4 and 2025 financial results, demonstrating a staggering 194% YoY revenue growth in 2025. Gross profit increased 197% YoY, with further improvements in Q4 with gross margins of 10.8%. We remain impressed by OGO’s financial results and expect continued rapid growth in 2026 with opportunity for M&A to push towards profitability. We are maintaining our BUY rating and $1.25/share target price on Organto Foods.
Q4 and 2025 Highlights
• OGO reported $60.8M in revenue in 2025 compared to our estimate of $60.1M. This represented 194% YoY growth, building on the 48% growth posted in 2024. Q4 Revenue was $14.9M (+132% YoY) vs. our estimate of $14.2M. Management attributed XYZ.
• Gross margin came in at 8.6% and 10.8% for the year and the quarter, respectively, nicely beating our estimates of 8.1% and 9.0%. Q4 represented OGO’s highest gross margins since Q3/24.
• 2025 EBITDA came in at $XXM vs. our estimate of ($0.8M) while Q4 EBITDA was ($0.3M) vs. our estimate of $0.2M. We remind readers that this is not adjusted for SBC. While OGO did not achieve its goal of being EBITDA positive in 2025, we believe it is on the right track and now is reaching the scale required.
• SG&A rose XYZ.
• OCF came in at $XXM for 2025 and $XXM for Q4.
• OGO ended the year with $6.2M in cash (incl. restricted cash) and $0.2M in debt. The balance sheet is in a strong place relative to OGO’s past, with a current ratio of XYZ.
Underlying
Organto Foods Inc
Provider
Atrium Research Corporation
Atrium Research provides institutional quality issuer paid research on North American public equities using deep fundamental analysis. Our research reports are disseminated through Bloomberg, FactSet, Capital IQ, Reuters and many more, as well as through our social media and email distribution lists.
Nicholas Cortellucci, CFA
Other Reports on these Companies
Other Reports from Atrium Research Corporation
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.